scispace - formally typeset
I

Ioannis Alexandros Charitos

Researcher at University of Bari

Publications -  57
Citations -  907

Ioannis Alexandros Charitos is an academic researcher from University of Bari. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 11, co-authored 39 publications receiving 358 citations.

Papers
More filters
Journal ArticleDOI

The Human Respiratory System and its Microbiome at a Glimpse

TL;DR: This review aims to deepen understanding of the essential physiological functions of the resident microbiome of the respiratory system on human health and diseases and analyzes in detail the functions and composition and the correct functionality of the microbiome in the light of current knowledge.
Journal ArticleDOI

A successful history: probiotics and their potential as antimicrobials.

TL;DR: The efficacy of probiotics for the supportive therapy of certain clinical conditions, especially infectious diseases, as reported in a number of studies are discussed, even though some concerns about their safety still remain.
Journal ArticleDOI

Oral Cancer: A Historical Review.

TL;DR: Modern oncologists and oral surgeons must learn a lot from their historic counterparts in order to avoid past unsuccessful efforts to treatment oral malignancies, and think that this disease might be linked to mechanisms not strictly dependent on environmental risk factors, and this might guide future research on oral cavity treatments towards strategical cellular and molecular techniques.
Journal ArticleDOI

Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective.

TL;DR: In this article, a review of the use of probiotics as adjuvant therapy for COVID-19 patients is presented, showing that probiotics can play a significant role in fighting SARS-CoV-2 infection, also compared with their use in the past for various diseases.
Journal ArticleDOI

Special features of SARS-CoV-2 in daily practice

TL;DR: Current medical knowledge and research on severe and critical patients’ management and experimental treatments are still evolving, but several protocols on minimizing risk of infection among the general population, patients and healthcare workers have been approved and diffused by International Health Authorities.